Here are 10 shortages of drugs on the GoodRx list, according to data from the FDA and the American Society of Health-System Pharmacists:
- Albuterol sulfate solution: Nephron Pharmaceuticals is releasing supplies as they become available, with increased demand cited as the reason for shortage.
- Amoxicillin powder: Shortages have persisted since fall 2022, with no release dates provided.
- Amphetamine mixed salts: Multiple formulations of the ADHD medication have been in shortage since 2022, with no release dates provided.
- Clonazepam: While the FDA reports one solution in shortage, the ASHP reports that 15 are in low supply, affecting treatment for anxiety and epilepsy disorders.
- Hydrocodone and acetaminophen tablets: Amneal reported manufacturing delays have led to a shortage of the pain relief medication.
- Ondansetron injection: Four solutions are in shortage.
- Prednisone oral tablets: The discontinuation of all Prednisone tablets by Cadista is contributing to the shortage, affecting 37 available solutions.
- Pantoprazole injection: The heartburn medication is in short supply, with efforts being made to increase availability.
- Sildenafil: This medication is set for discontinuation, affecting its availability.
- Zolpidem: The sleep aid drug has been discontinued.
